-
This Undervalued Cannabis Stock Has Another Year Of Growth: Reports Record 2023 Revenue And Adjusted EBITDA
Monday, April 29, 2024 - 10:39am | 672Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) reported its audited financial results on Monday for the three and twelve month periods ending Dec. 31, 2023. The Alberta-based company said it saw a record net revenue of CA$116 million ($84.8 million) in 2023, an increase of 46% over 2022....
-
Cannabis Extractor LEEF Brands Sees Stronger Margins And EBITDA In Q1, CEO Explains Why
Thursday, April 18, 2024 - 9:24am | 588Vertical cannabis operator LEEF Brands, Inc. (CSE:LEEF) (OTC:LEEEF) announced the release of its audited financial statements for the year ended 2023 on Thursday along with interim financial statements for the first quarter of fiscal 2024. "I am proud of the team and their performance in the past...
-
Israeli 'Cannabis Sticks' Maker Reports Financial Results For 2023 Following Reverse Takeover
Monday, April 8, 2024 - 12:29pm | 666Israeli technology and cannabinoid company StickIt Technologies Inc. (CSE:STKT) announced its financial results on Monday for the year ended Dec. 31, 2023. Revenue for the fiscal 2023 amounted to CA$203 000 ($149,300), compared to CA$564 000 in the prior year. The company called 2023 a "notable...
-
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
Thursday, February 29, 2024 - 11:47pm | 747Nasdaq-listed, GH Research (NASDAQ:GHRS) is a clinical-stage biopharma business developing novel 5-MeO-DMT therapies as transformative treatment of psychiatric and neurological disorders. Its reported yearly financial results show: Cash position of $ 222.7 million by December 31, 2023, an 11.5%...
-
Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment
Thursday, February 29, 2024 - 4:16pm | 749Compass Pathways (NASDAQ:CMPS), one of the key players in the psychedelics biotech space, reported its financial results for the fourth quarter of 2023. Numbers: Cash and cash equivalents were $220.2 million by December 31, 2023, up over 50% as compared to the amount held by December 31, 2022 ($...
-
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
Wednesday, February 28, 2024 - 3:52pm | 606Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) announced its financial results for the year ended December 31, 2023 along with a business update. Numbers: Cash and cash equivalents totaled $99.7 million by Dec. 31, 2023, an almost 30% reduction compared to the $142.1 million held by December 31, 2022...
-
Canadian Cannabis Retail Giant High Tide Narrows Net Loss YoY, Reports 37% Revenue Growth In 2023
Tuesday, January 30, 2024 - 10:13am | 707High Tide Inc. (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA) filed its year-end audited 2023 and fourth quarter financial results on Monday. Revenue rose by 37% year-over-year to CA$487.7 million ($362.8 million) in 2023, and 2% sequentially to CA$127.1 million in the fourth fiscal quarter. The Calgary,...